Correlation Between Furukawa Electric and Nektar Therapeutics

Can any of the company-specific risk be diversified away by investing in both Furukawa Electric and Nektar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Furukawa Electric and Nektar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Furukawa Electric Co and Nektar Therapeutics, you can compare the effects of market volatilities on Furukawa Electric and Nektar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Furukawa Electric with a short position of Nektar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Furukawa Electric and Nektar Therapeutics.

Diversification Opportunities for Furukawa Electric and Nektar Therapeutics

-0.1

Correlation Coefficient

Furukawa Electric  Nektar Therapeutics

Good diversification

The 3 months correlation between Furukawa and Nektar is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Furukawa Electric Co and Nektar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nektar Therapeutics and Furukawa Electric is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Furukawa Electric Co are associated (or correlated) with Nektar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nektar Therapeutics has no effect on the direction of Furukawa Electric i.e., Furukawa Electric and Nektar Therapeutics go up and down completely randomly.

Pair Corralation between Furukawa Electric and Nektar Therapeutics

Assuming the 90 days horizon Furukawa Electric Co is expected to generate 0.93 times more return on investment than Nektar Therapeutics. However, Furukawa Electric Co is 1.08 times less risky than Nektar Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Nektar Therapeutics is currently generating about 0.01 per unit of risk. If you would invest  3,800  in Furukawa Electric Co on December 22, 2024 and sell it today you would earn a total of  1,030  from holding Furukawa Electric Co or generate 27.11% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Furukawa Electric Co  vs.  Nektar Therapeutics

Furukawa Electric

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Furukawa Electric Co are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Furukawa Electric reported solid returns over the last few months and may actually be approaching a breakup point.

Nektar Therapeutics

Risk-Adjusted Performance

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Nektar Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable basic indicators, Nektar Therapeutics is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Furukawa Electric and Nektar Therapeutics

The main advantage of trading using opposite Furukawa Electric and Nektar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Furukawa Electric position performs unexpectedly, Nektar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nektar Therapeutics will offset losses from the drop in Nektar Therapeutics' long position.

The idea behind Furukawa Electric Co and Nektar Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.